Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Non-Current Deferred Tax Liability: 2013-2018

Historic Non-Current Deferred Tax Liability for Armata Pharmaceuticals (ARMP) over the last 5 years, with Sep 2018 value amounting to $1.1 million.

  • Armata Pharmaceuticals' Non-Current Deferred Tax Liability changed negligibly% to $1.1 million in Q3 2018 from the same period last year, while for Sep 2018 it was $1.1 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $1.1 million for FY2017, which is 53.16% down from last year.
  • Per Armata Pharmaceuticals' latest filing, its Non-Current Deferred Tax Liability stood at $1.1 million for Q3 2018, which was down 0.00% from $1.1 million recorded in Q2 2018.
  • In the past 5 years, Armata Pharmaceuticals' Non-Current Deferred Tax Liability registered a high of $3.1 million during Q1 2014, and its lowest value of $1.1 million during Q2 2017.
  • Its 3-year average for Non-Current Deferred Tax Liability is $1.9 million, with a median of $1.1 million in 2018.
  • Data for Armata Pharmaceuticals' Non-Current Deferred Tax Liability shows a maximum YoY slumped of 61.83% (in 2017) over the last 5 years.
  • Quarterly analysis of 5 years shows Armata Pharmaceuticals' Non-Current Deferred Tax Liability stood at $3.1 million in 2014, then declined by 2.37% to $3.0 million in 2015, then dropped by 18.50% to $2.4 million in 2016, then plummeted by 53.16% to $1.1 million in 2017, then remained steady at $1.1 million in 2018.
  • Its Non-Current Deferred Tax Liability stands at $1.1 million for Q3 2018, versus $1.1 million for Q2 2018 and $1.1 million for Q1 2018.